… ; dysregulated metabolism plays an important role in cancer development [68]. Clementino et
al. have found that c-Myc mediated aberrant histone acetylation contributes … multiple routes, …

… miR-181a-5p overexpression in IRBP-specific Th17 cells leads to a significantly less
pathogenic EAU phenotype, strongly confirming the T cell-intrinsic role of miR-181a-5p in …

… multiple cancers including liver hepatocellular carcinoma (LIHC), head and neck squamous
cell carcinoma (HNSCC) and lung squamous cell carcinoma (… a tumor suppressor in multiple …

… all of which contribute to Polycomb gene silencing potentially through different … hepatocellular
carcinoma, EZH2’s noncanonical function is also involved [79]. Here, in animal liver tumors …

… epigenetic changes in the genome, which eventually leads … products modulate the dysregulated
signaling pathways by … in vivo models of hepatocellular carcinoma. MiRNA chip analysis …

… -type-dependent [14, 19, 20], suggesting that c-Myc-mediated immune regulation … of
many important biological pathways, the c-Myc oncogene contributes to the genesis of multiple …

… genes are often dysregulated in cancer cells. These genomic … epigenetically, which leads
to tumor progression through … alter these multiple pathways and treat cancer without leaving a …

… in HCC patients when compared with chronic HCV without and with cirrhosis patients (p <
0.01). The contribution of … in many tumors to play oncogenic roles in cancer development and …

… Recent studies have found that lncRNA also contributes to the development of glioma [8]
and closely relates to patients' prognosis [9, 10]. MEG3(maternally expressed 3) can interact …

… Wang L, Zhang X, Jia LT, et al. c-Myc-mediated epigenetic silencing of MicroRNA-101
contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology. 2014;…